Eoganacht ... Accurate.
The link to the online journal was provided by Enrique earlier today:
Neuro-Oncology Advances ACCEPTED MANUSCRIPT
Efficacy of Ruthenium coordination complex based Rutherrin in a pre-clinical rat glioblastoma(GBM) model
Manjunatha Akathatti Munegowda Carl Fisher Daniel Molehuis Warren Foltz Mark Roufaiel Jay Bassan Mark Nitz Arkady Mandel Lothar Lilge
Published: 28 May 2019
If you click on the PDF link and go to the last paragraph of page 20 you will see:
"Rutherrin-PDT was well tolerated, providing safe and effective treatment of RG-2 glioma. Rutherrin mediated PDT response appears superior to ALA-PpIX mediated PDT. In our
unpublished clinical study, photosensitizer present in Rutherrin formulation has not shown any phototoxicity, excluding patients from avoiding light sources. With these positive PDT results
and the ability to absorb light at longer wavelengths, resistance photobleaching, Rutherrin is a promising photosensitizer formulation to target brain cancer."
hydrocarbss wrote:fredgoodwinson wrote
'In our unpublished clinical study, photosensitizer present in Rutherrin formulation has not shown any phototoxicity, excluding patients from avoiding light sources.'
I questioned the source.
B$ reply: billiondolarman - (6/26/2019 3:24:17 PM) RE:RE:RE:RE:RE:Rutherrin Todays news release. If you take the time to read it.>>>BDM
My response: That statement, re: an unpublished clinical study...
cannot be found in the news release of June 26, 2019 from Theralase.